Algert Global LLC Makes New Investment in Definitive Healthcare Corp. (NASDAQ:DH)

Algert Global LLC acquired a new position in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 231,644 shares of the company's stock, valued at approximately $1,265,000. Algert Global LLC owned about 0.20% of Definitive Healthcare as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Susquehanna Fundamental Investments LLC raised its holdings in shares of Definitive Healthcare by 1,031.3% during the second quarter. Susquehanna Fundamental Investments LLC now owns 167,584 shares of the company's stock worth $915,000 after purchasing an additional 152,770 shares during the period. The Manufacturers Life Insurance Company raised its stake in Definitive Healthcare by 17.0% during the second quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company's stock worth $125,000 after acquiring an additional 3,332 shares during the period. Millennium Management LLC bought a new position in Definitive Healthcare in the second quarter worth about $9,283,000. AQR Capital Management LLC bought a new position in shares of Definitive Healthcare during the second quarter valued at approximately $155,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of Definitive Healthcare by 213.8% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 219,481 shares of the company's stock worth $1,198,000 after purchasing an additional 149,533 shares during the period. Institutional investors own 98.67% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have commented on DH shares. Barclays dropped their price target on shares of Definitive Healthcare from $6.00 to $4.00 and set an "equal weight" rating on the stock in a research note on Wednesday, August 7th. Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research report on Tuesday, August 6th. Morgan Stanley decreased their price target on Definitive Healthcare from $9.00 to $5.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 6th. Robert W. Baird cut their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Definitive Healthcare from $7.00 to $5.00 and set a "hold" rating for the company in a research report on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $5.81.

Definitive Healthcare Price Performance

Shares of NASDAQ DH traded down $0.01 during midday trading on Friday, reaching $4.34. The company's stock had a trading volume of 262,360 shares, compared to its average volume of 801,001. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62. The company has a market cap of $511.84 million, a price-to-earnings ratio of -2.48, a price-to-earnings-growth ratio of 6.49 and a beta of 1.33. The company has a 50 day moving average price of $4.32 and a 200 day moving average price of $5.59. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.27.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09. The company had revenue of $63.70 million for the quarter, compared to analysts' expectations of $63.19 million. Definitive Healthcare had a positive return on equity of 0.98% and a negative net margin of 156.65%. The firm's revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.08 earnings per share. On average, equities research analysts expect that Definitive Healthcare Corp. will post 0.07 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.